Evorpacept (ALX148)
22-0110.cc
Phase 2 small_molecule active
Quick answer
Evorpacept (ALX148) for Microsatellite Stable Metastatic Colorectal Cancer is a Phase 2 program (small_molecule) at ALX ONCOLOGY HOLDINGS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALX ONCOLOGY HOLDINGS INC
- Indication
- Microsatellite Stable Metastatic Colorectal Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active